Showing results (1-10 of 176) with videos related to
Sort By:
Pageof 18
Haematologica|October 16, 2012
Brentuximab vedotin in refractory CD30+ lymphomas: a bridge to allogeneic transplantation in approximately one quarter of patients treated on a Named Patient Programme at a single UK centerAdam Gibb, Craig Jones, Adrian Bloor, et al.The New England Journal of Medicine|April 23, 2015
Results of a trial of PET-directed therapy for early-stage Hodgkin's lymphomaJohn Radford, Tim Illidge, Nicholas Counsell, et al.Best Practice & Research. Clinical Haematology|June 11, 2011
Radioimmunotherapy in follicular lymphomaTim Illidge, Franck MorschhauserLeukemia & Lymphoma|April 10, 2008
Current treatment approaches for diffuse large B-cell lymphomaTim Illidge, Shaun TolanLeukemia & Lymphoma|July 8, 2008
How have outcomes for patients with follicular lymphoma changed with the addition of monoclonal antibodies?Tim Illidge, Clara ChanThe Journal of Pharmacy and Pharmacology|July 23, 2008
New insights into the mechanisms of action of radioimmunotherapy in lymphomaAndrei Ivanov, Ruth Swann, Tim IllidgeCurrent Opinion in Urology|August 24, 2016
Immunotherapy with radiotherapy in urological malignanciesShaveta Mehta, Tim Illidge, Ananya ChoudhuryClinical Medicine (London, England)|October 5, 2017
New horizons in multimodality molecular imaging and novel radiotracersSally Barrington, Philip Blower, Gary CookCancer|July 11, 2006
Recommendations for the use of yttrium-90 ibritumomab tiuxetan in malignant lymphomaOliver Weigert, Tim Illidge, Wolfgang Hiddemann, et al.Pageof 18